Skip to Content
You are currently on the new version of our website. Access the old version .

2,385 Results Found

  • Article
  • Open Access
35 Citations
7,768 Views
13 Pages

Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study

  • Diego Santos García,
  • Carmen Labandeira Guerra,
  • Rosa Yáñez Baña,
  • Maria Icíar Cimas Hernando and ,
  • Iria Cabo López,
  • Jose Manuel Paz Gonález,
  • Maria Gemma Alonso Losada,
  • María José González Palmás and
  • Cristina Martínez Miró
  • + 4 authors+ 0 author

Some studies observed a benefit of Parkinson’s disease (PD) patients after treatment with safinamide in some non-motor symptoms (NMSs). The aim of this study was to analyze the effectiveness of safinamide on NMS burden in PD. SAFINONMOTOR (an open-la...

(This article belongs to the Section Behavioral Neuroscience)
  • Article
  • Open Access
2 Citations
983 Views
10 Pages

29 January 2026

Open-label placebos (OLPs) have demonstrated benefits across multiple conditions; however, the factors influencing their acceptance or rejection remain unclear. This study aimed to examine the relationship between willingness to take an OLP pill and...

  • Article
  • Open Access
27 Citations
7,921 Views
16 Pages

Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study

  • Diego Santos García,
  • Maria Gema Alonso Losada,
  • Icíar Cimas Hernando,
  • Iria Cabo López and ,
  • Rosa Yáñez Baña,
  • Ruben Alonso Redondo,
  • Jose Manuel Paz González,
  • Carlos Cores Bartolomé,
  • Maria José Feal Painceiras and
  • Iago García Díaz
  • + 7 authors+ 2 authors

29 October 2022

Depression is frequent in Parkinson’s disease (PD) patients, but the evidence for many antidepressant agents to treat it in PD is insufficient. The aim of the present prospective open-label single-arm study (VOPARK, an open-label study of the e...

(This article belongs to the Section Neurodegenerative Diseases)
  • Article
  • Open Access
16 Citations
5,694 Views
13 Pages

Stress belongs to the most frequent negative feelings people are confronted with in daily life. Strategies against acute stress include, e.g., relaxation techniques or medications, but it is also known that placebos can successfully reduce negative e...

(This article belongs to the Special Issue Neurofunctional and Neurochemical Signatures of Emotional and Cognitive Processes and Competencies)
  • Article
  • Open Access
1 Citations
2,491 Views
9 Pages

Effects of Open-Label Placebos on Visual Food Cue Reactivity in Children and Adolescents

  • Anne Schienle,
  • Alice Polz,
  • Katharina Haslacher,
  • Florian Osmani and
  • Wolfgang Kogler

30 October 2024

Background: A high level of food cue reactivity (FCR) is a risk factor for overeating and weight gain. This randomized trial investigated whether open-label placebos (OLPs: placebos honestly administered) can reduce FCR (reported appetite) in childre...

(This article belongs to the Section Pediatric Gastroenterology and Nutrition)
  • Article
  • Open Access
56 Citations
2,708 Views
8 Pages

A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain

  • Neil Hagen,
  • B. Lapointe,
  • M. Ong-Lam,
  • B. Dubuc and ,
  • D. Walde,
  • B. Gagnon,
  • R. Love,
  • R. Goel,
  • P. Hawley and
  • P. du Souich
  • + 6 authors+ 1 author

1 June 2011

Background: Cancer pain is highly prevalent, and existing treatments are often insufficient to provide adequate relief. Objectives: We assessed the long-term safety and efficacy of subcutaneous tetrodotoxin treatment in reducing the intensity of chro...

  • Article
  • Open Access
1,945 Views
8 Pages

29 May 2024

It has been posited that ingesting a pill constitutes a pivotal action that facilitates the effects of open-label placebos (OLPs: placebos honestly prescribed). In the present OLP experiment, the motor components of a placebo treatment were systemati...

(This article belongs to the Section Psychiatric, Emotional and Behavioral Disorders)
  • Article
  • Open Access
21 Citations
6,748 Views
14 Pages

Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study

  • Diego Santos García,
  • Gustavo Fernández Pajarín,
  • Juan Manuel Oropesa-Ruiz,
  • Francisco Escamilla Sevilla and ,
  • Raúl Rashid Abdul Rahim López and
  • José Guillermo Muñoz Enríquez
  • + 1 author+ 0 author

Patients with Parkinson’s disease (PD) can improve some non-motor symptoms (NMS) after starting treatment with opicapone. The aim of this study was to analyze the effectiveness of opicapone on global NMS burden in PD. OPEN-PD (Opicapone Effecti...

(This article belongs to the Special Issue Non-motor Disorders in Parkinson Disease: Basic Science and Advances in Treatment)
  • Protocol
  • Open Access
2,676 Views
11 Pages

Protocol for a Randomized, Open-Label Clinical Trial on the Effect of Mouthwash on Salivary SARS-CoV-2 Load

  • Keiji Konishi,
  • Daisuke Onozuka,
  • Satoko Takatera,
  • Hiroo Matsuo and ,
  • Hisao Yoshida,
  • Shigeto Hamaguchi,
  • Shungo Yamamoto,
  • Ryuichi Minoda Sada,
  • Koichiro Suzuki and
  • Satoshi Kutsuna
  • + 5 authors+ 0 author

8 December 2023

Mouthwashes containing cetylpyridinium chloride (CPC) or on-demand aqueous chlorine dioxide (ACD) have potential to reduce the salivary severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) load in individuals with SARS-CoV-2 infection. This s...

(This article belongs to the Special Issue Current Research on SARS-CoV-2)
  • Article
  • Open Access
19 Citations
5,434 Views
12 Pages

Acceptability, Swallowability, Palatability, and Safety of Multiple Film-Coated Mini-Tablets in Children Aged ≥2–<7 Years: Results of an Open-Label Randomised Study

  • Juliane Münch,
  • Carolin Kloft,
  • Madhi Farhan,
  • Vladislav Fishman and ,
  • Sining Leng,
  • Hans Martin Bosse and
  • Viviane Klingmann
  • + 2 authors+ 0 author

This single-centre, open-label, randomised, parallel-group study assessed the acceptability, swallowability, palatability, and safety of film-coated, 3 mm diameter mini-tablets in children aged ≥2–<7 years. In total, 300 participants were...

(This article belongs to the Section Drug Delivery and Controlled Release)
  • Article
  • Open Access
1,120 Views
16 Pages

Longitudinal Adaptive Functioning Outcomes in Children with Autism Spectrum Disorder During a 180 Day Open-Label Extension of K11-Tmax, a Consortium Probiotic Mix with Multivitamins

  • Deivis O. Guimaraes,
  • Racire S. Silva,
  • Lara A. Ferreira,
  • Larissa Martinelli and ,
  • Rebeca M. M. Werly,
  • Raphaela F. Amorim,
  • Lívia B. S. S. Holzbach,
  • Roberto Badaró,
  • Alex A. B. Santos and
  • Sarha A. L. de Queiroz
  • + 6 authors+ 1 author

2 June 2026

Autism spectrum disorder (ASD) is frequently associated with gastrointestinal symptoms, immune dysregulation, and altered microbiota-related signaling, supporting interest in microbiota-targeted interventions. This study evaluated adaptive functionin...

(This article belongs to the Section Microbiology)
  • Article
  • Open Access
4 Citations
1,328 Views
6 Pages

An Open-Label Multicenter Safety, Tolerability, and Efficacy Study of Recombinant Granulocyte Colony-Stimulating Factor in the Prevention of Neutropenic Complications in Breast Cancer Patients

  • Audrius Sveikata,
  • Sigita Liutkauskienė,
  • Elona Juozaitytė,
  • Dainius Characiejus and ,
  • Laimutė Tamošaitytė and
  • Kastytis Šeštakauskas
  • + 1 author+ 0 author

5 September 2011

The primary objective of this open-label, two chemotherapy arm, phase 4 study was to evaluate the safety and efficacy of newly developed recombinant granulocyte colony-stimulating factor (rG-CSF) used to prevent neutropenia-related complications in p...

  • Article
  • Open Access
6 Citations
1,266 Views
12 Pages

An Open-Label Expanded-Access Trial of Bendamustine in Patients with Rituximab-Refractory Indolent Non-Hodgkin Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia: BEND-ACT

  • C.T. Kouroukis,
  • M. Crump,
  • D. MacDonald,
  • J.F. Larouche and ,
  • D.A. Stewart,
  • J. Johnston,
  • S. Sauvageau,
  • E. Beausoleil,
  • P. Sage and
  • L. Sehn
  • + 8 authors+ 3 authors

1 August 2015

Background: Bendamustine is a bifunctional alkylating agent with unique properties that distinguish it from other agents in its class. Bendamustine is used as monotherapy or in combination with other agents to treat patients with non-Hodgkin lymphoma...

  • Article
  • Open Access
1 Citations
2,997 Views
12 Pages

27 June 2025

Background/Objective: Hypertension and other modifiable risk factors for cardiovascular disease are characterized by a dysfunctional vascular endothelium and decreased nitric oxide (NO) bioavailability. The oral supplementation of inorganic nitrate (...

(This article belongs to the Section Pharmacology)
  • Systematic Review
  • Open Access
25 Citations
7,371 Views
15 Pages

The Effects of Transcranial Direct Current Stimulation in Obsessive–Compulsive Disorder Symptoms: A Meta-Analysis and Integrated Electric Fields Modeling Analysis

  • Bianca Silva Pinto,
  • Beatriz Araújo Cavendish,
  • Pedro Henrique Rodrigues da Silva,
  • Paulo Jeng Chian Suen and ,
  • Kalian Almeida Pereira Marinho,
  • Leandro da Costa Lane Valiengo,
  • Marie-Anne Vanderhasselt,
  • André Russowsky Brunoni and
  • Laís Boralli Razza
  • + 4 authors+ 0 author

Transcranial direct current stimulation (tDCS) has been showing promising effects for the treatment of obsessive–compulsive disorder (OCD), but there is still no conclusion on its efficacy for this disorder. We performed a systematic review and...

(This article belongs to the Special Issue Neuromodulation from Theory to Therapy)
  • Article
  • Open Access
1,182 Views
18 Pages

A Reproducible Reference Architecture for Automated Driving Scenario Databases

  • Yavar Taghipour Azar,
  • Juan Diego Ortega and
  • Marcos Nieto

As automated vehicles move from controlled environments to unpredictable real-world roads, scenario-based testing has become the cornerstone of safety validation. In recent years, substantial progress has been made in scenario representation standard...

  • Protocol
  • Open Access
6 Citations
6,530 Views
14 Pages

Can an Open-Label Placebo Be as Effective as a Deceptive Placebo? Methodological Considerations of a Study Protocol

  • Leo Druart,
  • SaraEve Graham Longsworth,
  • Carole Rolland,
  • Maïa Dolgopoloff and ,
  • Hugo Terrisse,
  • Jean-Luc Bosson and
  • Nicolas Pinsault
  • + 2 authors+ 0 author

Background: Placebo has been studied for many years and is ever-present in healthcare. In clinical practice, its use is limited by ethical issues raised by the deception entailed by its administration. Objective: To investigate whether, when given de...

  • Article
  • Open Access
19 Citations
8,219 Views
18 Pages

iLDM: An Interoperable Graph-Based Local Dynamic Map

  • Mikel García,
  • Itziar Urbieta,
  • Marcos Nieto,
  • Javier González de Mendibil and
  • Oihana Otaegui

8 January 2022

Local dynamic map (LDM) is a key component in the future of autonomous and connected vehicles. An LDM serves as a local database with the necessary tools to have a common reference system for both static data (i.e., map information) and dynamic data...

(This article belongs to the Special Issue Electrified Intelligent Transportation Systems)
  • Article
  • Open Access
9 Citations
5,617 Views
19 Pages

Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study

  • Noriko Tomita,
  • Eriko Morino,
  • Junko Terada-Hirashima,
  • Yukari Uemura and ,
  • Yosuke Shimizu,
  • Sho Saito,
  • Tetsuya Suzuki,
  • Nobumasa Okumura,
  • Haruka Iwasaki and
  • Mugen Ujiie
  • + 9 authors+ 4 authors

14 March 2023

Monkeypox (mpox) is an acute exanthematous disease caused by the monkeypox virus (MPXV). Since May 2022, patients with mpox have been reported worldwide, mainly in Europe and the Americas. In Japan, LC16”KMB,” which is a smallpox vaccine...

(This article belongs to the Section Medical Research)
  • Article
  • Open Access
1 Citations
925 Views
16 Pages

Agaro-Oligosaccharide Supplementation Alters the Gut Microbiota, Revealing Potential Agaro-Oligosaccharide-Utilizing Taxa in Healthy Japanese Adults

  • Natasia Hoshiba,
  • Tadashi Fujii,
  • Rina Yagasaki,
  • Toshiyuki Ochi and ,
  • Katsuhiro Shiba,
  • Hideaki Takahashi,
  • Kohei Funasaka,
  • Eizaburo Ono,
  • Yoshiki Hirooka and
  • Koji Karasawa
  • + 6 authors+ 1 author

Background: Agaro-oligosaccharides (AOS) have been shown to modulate the gut microbiota in in vitro and animal studies; however, human evidence remains scarce. Methods: Herein, we conducted a four-week open-label, single-arm, non-randomized pilot tri...

(This article belongs to the Section Microbiology in Human Health and Disease)
  • Article
  • Open Access
16 Citations
9,578 Views
15 Pages

18 December 2023

Objective: This was an open-label pilot study to test the feasibility and preliminary efficacy of a wearable digital intervention developed to improve on-task behavior. This was an exploratory study to test for specificity of response on parent- and...

(This article belongs to the Special Issue Advances in ADHD—Second Edition)
  • Article
  • Open Access
2 Citations
3,501 Views
20 Pages

18 November 2024

Open-world object detection (OWOD) focuses on training models with partially known class labels, enabling the detection of objects from known classes while concurrently identifying objects from unknown classes. Current models often perform suboptimal...

  • Article
  • Open Access
3,456 Views
15 Pages

Effects of Medical Cannabis Treatment for Autistic Children on Family Accommodation: An Open-Label Mixed-Methods Study

  • Ayelet David,
  • Eynat Gal,
  • Ayelet Ben-Sasson,
  • Elkana Kohn and ,
  • Matitiahu Berkovitch and
  • Orit Stolar
  • + 1 author+ 0 author

11 October 2025

Background/Objectives: Parents of autistic children often face behavioral and participation challenges of their children, leading them to make accommodations to maintain a stable daily family routine. These family accommodations (FA) involve adapting...

(This article belongs to the Special Issue Children and Adolescents with Neurodevelopmental Disabilities: Ecological Assessment Tools and Cognitive Analysis)
  • Article
  • Open Access
2 Citations
3,086 Views
13 Pages

Short Answer Detection for Open Questions: A Sequence Labeling Approach with Deep Learning Models

  • Samuel González-López,
  • Zeltzyn Guadalupe Montes-Rosales,
  • Adrián Pastor López-Monroy,
  • Aurelio López-López and
  • Jesús Miguel García-Gorrostieta

28 June 2022

Evaluating the response to open questions is a complex process since it requires prior knowledge of a specific topic and language. The computational challenge is to analyze the text by learning from a set of correct examples to train a model and then...

(This article belongs to the Special Issue New Machine Learning and Deep Learning Techniques in Natural Language Processing)
  • Article
  • Open Access
17 Citations
5,211 Views
20 Pages

Systematic Evaluation of the T30 Neurostimulator Treatment for Tinnitus: A Double-Blind Randomised Placebo-Controlled Trial with Open-Label Extension

  • Deborah Ann Hall,
  • Robert Henryk Pierzycki,
  • Holly Thomas,
  • David Greenberg and ,
  • Magdalena Sereda and
  • Derek James Hoare
  • + 1 author+ 0 author

26 February 2022

Tinnitus is often triggered by cochlear damage and has been linked with aberrant patterns of neuronal activity. Acoustic Coordinated Reset (CR®) Neuromodulation is a sound therapy hypothesised to reduce tinnitus symptoms by desynchronising pathol...

(This article belongs to the Special Issue Neural Plasticity in Tinnitus Mechanisms)
  • Article
  • Open Access
2 Citations
3,400 Views
18 Pages

17 November 2025

This study presents the development of an AI-powered chatbot designed to facilitate accurate and efficient retrieval of information from the FDA drug labeling documents. Leveraging OpenAI’s GPT-3.5-turbo model within a controlled, document-grou...

  • Article
  • Open Access
9 Citations
13,839 Views
11 Pages

Nitric Oxide Generating Formulation as an Innovative Approach to Topical Skin Care: An Open-Label Pilot Study

  • Stephan Settelmeier,
  • Tienush Rassaf,
  • Ulrike B. Hendgen-Cotta and
  • Ingo Stoffels

16 February 2021

Nitric oxide (NO) plays multiple roles in both normal and abnormal skin processes. Its deranging disbalance is involved in the pathogenesis of multiple dermatologic diseases such as acne vulgaris, pointing towards beneficial therapeutic directions. A...

(This article belongs to the Special Issue Feature Papers in Cosmetics in 2020)
  • Article
  • Open Access
2,582 Views
15 Pages

Evaluation of the Interest in and Tolerance of a Topical Emollient in the Management of Canine Nasal Hyperkeratosis: An Open-Label, Prospective, Uncontrolled Pilot Study

  • Sébastien Viaud,
  • Sarah Pariente,
  • Bruno Jahier,
  • Christelle Navarro and ,
  • Cécile Destaing and
  • Carole Gard
  • + 1 author+ 0 author

22 August 2025

(1) Background: Idiopathic or familial nasal hyperkeratosis (NHK) may be considered a cosmetic issue in its uncomplicated form. Nevertheless, the prevention of secondary lesions could be advised by proper management. (2) Methods: In this multicentre,...

  • Article
  • Open Access
5 Citations
2,739 Views
13 Pages

Improvements in the Effectiveness of Early Detection in Colorectal Cancer with Open-Label Randomised Study

  • A. Álvarez-Delgado,
  • M. L. Pérez García,
  • J. M. García-González,
  • H. Iglesias de Sena and ,
  • A. J. Chamorro,
  • M. F. Lorenzo Gómez,
  • M. Marcos and
  • J. A. Mirón-Canelo
  • + 3 authors+ 0 author

29 October 2021

Introduction: The general objective of this research is to improve the quality of colorectal cancer screening (CRC) by assessing, as an indicator of effectiveness, the ability of colonoscopy to detect more advanced adenomas in the exposed group than...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Protocol
  • Open Access
1 Citations
4,390 Views
20 Pages

Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol

  • J. Kim Penberthy,
  • Fatma A. Wise,
  • Nicholas Cherup,
  • J. Morgan Penberthy and ,
  • Evaline Mitchell,
  • Madeline Burns,
  • Oluwafunmilayo Akinlade,
  • David Chung,
  • Harshit Parmar and
  • Jonathan Singer
  • + 5 authors+ 0 author

Prolonged grief disorder (PGD) affects approximately 10% of bereaved individuals and is now formally recognized in both the DSM-5-TR and ICD-11. Despite its prevalence, PGD often responds poorly to traditional therapeutic approaches. This manuscript...

(This article belongs to the Special Issue New Psychoactive Substances and Emerging Trends: Pharmacology, Neurotoxicity and Public Health Implications)
  • Article
  • Open Access
7 Citations
4,757 Views
9 Pages

Modulation of Free Amino Acid Profile in Healthy Humans Administered with Mastiha Terpenes. An Open-Label Trial

  • Efstathia Papada,
  • Ljilja Torović,
  • Charalampia Amerikanou,
  • Nikolaos Kalogeropoulos and ,
  • Ilias Smyrnioudis and
  • Andriana C. Kaliora
  • + 1 author+ 0 author

3 June 2018

We aimed to explore whether plasma-free amino acids are modified in response to terpenes administration in healthy humans. In this open-label, single-arm acute trial, seventeen healthy male volunteers were administered with a naturally occurring prod...

  • Article
  • Open Access
19 Citations
7,632 Views
13 Pages

Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study

  • Eigild Møller,
  • Søren Anker Pedersen,
  • Pablo Gustavo Vinicoff,
  • Allan Bardow and ,
  • Joan Lykkeaa,
  • Pia Svendsen and
  • Merete Bakke
  • + 2 authors+ 0 author

30 June 2015

The aim of this prospective open-label study was to treat disabling drooling in children with cerebral palsy (CP) with onabotulinumtoxin A (A/Ona, Botox®) into submandibular and parotid glands and find the lowest effective dosage and least invasive m...

(This article belongs to the Collection Botulinum Toxins on Human Pain)
  • Article
  • Open Access
2,197 Views
9 Pages

Effectiveness of a Multidisciplinary Headache Management Program: An Open-Label Pilot Study

  • Rini Souren,
  • Balz Ronald Winteler,
  • Nina Bischoff,
  • Oliver Fluri and ,
  • Johannes Grolimund,
  • Adrian Scutelnic,
  • Konrad Streitberger,
  • David Beckwée and
  • Christoph J. Schankin
  • + 4 authors+ 0 author

Migraine is a common disabling primary headache disorder with significant personal and socio-economic impacts. A combination of medication and non-pharmacological therapies is essential for migraine management. Outpatient multidisciplinary headache t...

(This article belongs to the Section Headache)
  • Article
  • Open Access
3 Citations
6,188 Views
10 Pages

Studies with adults and school children have shown that placebos can enhance motivation and performance in physical activities. This study aimed to investigate whether similar effects are present in kindergarten-aged children. A total of 101 children...

  • Article
  • Open Access
3 Citations
3,656 Views
11 Pages

Palatability and Swallowability of Pimavanserin When Mixed with Selected Food Vehicles: An Exploratory Open-Label Crossover Study

  • Mark Forman,
  • Alex Kouassi,
  • Teresa Brandt,
  • Lee Barsky and ,
  • Cynthia Zamora and
  • Daryl Dekarske
  • + 1 author+ 0 author

Dysphagia (difficulty swallowing) affects up to 13% of persons 65 years and older and 51% of older persons in nursing homes and can contribute to reduced adherence to oral medications. This was an exploratory, single-center, open-label, randomized, c...

(This article belongs to the Section Dysphagia)
  • Comment
  • Open Access
1 Citations
1,004 Views
4 Pages

I read with interest the recently published open-label randomized trial comparing a single ivy extract with two herbal combination therapies (ivy/thyme and thyme/primrose) for the treatment of acute bronchitis [...]

  • Article
  • Open Access
31 Citations
8,854 Views
9 Pages

Effects of Probiotic Strains on Disease Activity and Enteric Permeability in Psoriatic Arthritis–A Pilot Open-Label Study

  • Andreas Haidmayer,
  • Philipp Bosch,
  • Angelika Lackner,
  • Monica D’Orazio and ,
  • Johannes Fessler and
  • Martin H Stradner
  • + 1 author+ 0 author

5 August 2020

(1) Background: Psoriatic Arthritis (PsA) is a painful disease of the joints and spine. Recent reports observed distinct enteric dysbiosis in PsA; intake of probiotic strains is considered to ameliorate enteric dysbiosis. If probiotics are effective...

(This article belongs to the Special Issue Role of Prebiotics and Probiotics in Health and Disease)
  • Article
  • Open Access
60 Citations
18,272 Views
14 Pages

7 June 2016

Autism spectrum disorders (ASD) are recognized as a major public health issue. Here, we evaluated the effects of folic acid intervention on methylation cycles and oxidative stress in autistic children enrolled in structured teaching. Sixty-six autist...

  • Article
  • Open Access
5 Citations
3,058 Views
9 Pages

Acceptability of Prednisolone in an Open-Label Randomised Cross-Over Study—Focus on Formulation in Children

  • Sissel Sundell Haslund-Krog,
  • Inger Merete Jørgensen,
  • Kim Dalhoff and
  • Helle Holst

16 August 2022

Developing acceptable medicines for children is a complicated task. Several factors must be considered, including age, physiology, texture preference, formulation, and legal framework among others. In the development of new paediatric medicines, thes...

(This article belongs to the Special Issue Challenges in Children's Medicine Treatments: From Off-Label Use to Extemporaneous Formulations)
  • Article
  • Open Access
672 Views
25 Pages

Machine Learning-Based Prediction of Treatment Response to Vitamin D3 in Adolescents and Young Adults with Inflammatory Bowel Disease: A Prospective, Open-Label, Alternation-Based Comparative Study

  • Marina Adriana Mercioni,
  • Adrian Goldiș,
  • Nina Holban,
  • Mihai Vasile Popescu and ,
  • Radu Dragomir,
  • Christian Goldiș,
  • Bianca Belei,
  • Ileana Enatescu,
  • Roxana Folescu and
  • Oana Belei
  • + 6 authors+ 1 author

Background: Chronic inflammatory bowel diseases (IBDs), specifically Crohn’s disease and ulcerative colitis, present substantial clinical challenges characterized by a relapsing-remitting course. These conditions often lead to serious complicat...

(This article belongs to the Special Issue Crohn's Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches (4th Edition))
  • Article
  • Open Access
13 Citations
3,880 Views
17 Pages

Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS)

  • Ellery Santos,
  • Courtney Clark,
  • Hazel Maridith B. Biag,
  • Si Jie Tang and ,
  • Kyoungmi Kim,
  • Matthew D. Ponzini,
  • Andrea Schneider,
  • Cecilia Giulivi,
  • Federica Alice Maria Montanaro and
  • Flora Tassone
  • + 14 authors+ 9 authors

5 December 2023

Fragile X (FMR1) premutation is a common mutation that affects about 1 in 200 females and 1 in 450 males and can lead to the development of fragile-X-associated tremor/ataxia syndrome (FXTAS). Although there is no targeted, proven treatment for FXTAS...

(This article belongs to the Special Issue The Molecular Basis of Fragile X Syndrome and Other FMR1-Associated Conditions)
  • Article
  • Open Access
2 Citations
4,137 Views
14 Pages

Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial

  • Toshihiro Nanki,
  • Mai Kawazoe,
  • Kiyoko Uno,
  • Wataru Hirose and ,
  • Hiroaki Dobashi,
  • Hiroshi Kataoka,
  • Toshihide Mimura,
  • Hiroshi Hagino and
  • Hajime Kono
  • + 4 authors+ 0 author

30 December 2022

This randomized, open-label, multicenter, parallel study imitating real-world clinical practice assessed the effect of switching to weekly teriparatide in patients with glucocorticoid-induced osteoporosis (GIO) with a lumbar spine/proximal femur bone...

(This article belongs to the Section Orthopedics)
  • Article
  • Open Access
3 Citations
3,299 Views
11 Pages

Evaluation of Internet-Connected Real-Time Remote Auscultation: An Open-Label Randomized Controlled Pilot Trial

  • Takahiro Ito,
  • Takanobu Hirosawa,
  • Yukinori Harada,
  • Shintaro Kakimoto and
  • Taro Shimizu

24 November 2022

The utility of remote auscultation was unknown. This study aimed to evaluate internet-connected real-time remote auscultation using cardiopulmonary simulators. In this open-label randomized controlled trial, the physicians were randomly assigned to t...

(This article belongs to the Topic eHealth and mHealth: Challenges and Prospects)
  • Article
  • Open Access
8 Citations
6,217 Views
13 Pages

Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study

  • Angelo Fassio,
  • Davide Gatti,
  • Maurizio Rossini,
  • Camilla Benini and ,
  • Elena Fracassi,
  • Eugenia Bertoldo,
  • Ombretta Viapiana,
  • Stefano Milleri,
  • Matteo Gatti and
  • Giovanni Adami
  • + 5 authors+ 0 author

2 July 2021

Comparative pharmacodynamic (PD) analyses on different dosing schedules for cholecalciferol supplementation are limited. This was an open-label, randomized, parallel-group study involving 75 healthy individuals deficient in vitamin D (baseline 25OHD...

(This article belongs to the Section Nutrition and Metabolism)
  • Article
  • Open Access
15 Citations
6,479 Views
12 Pages

Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase

  • Masahiro Abo,
  • Takashi Shigematsu,
  • Hiroyoshi Hara,
  • Yasuko Matsuda and ,
  • Akinori Nimura,
  • Yoshiyuki Yamashita and
  • Kaoru Takahashi
  • + 2 authors+ 0 author

18 February 2020

In many countries, 400 units (U) is the maximum dose of onabotulinumtoxinA available to treat upper limb spasticity, but few studies have demonstrated the optimal use of this dose. In the double-blind phase of this randomized, controlled trial, we co...

  • Article
  • Open Access
33 Citations
752 Views

Background: An open-label, noncomparative study was conducted to assess the safety and efficacy of ciclopirox 8% nail lacquer topical solution in patients with type 2 diabetes mellitus. Methods: Forty-nine diabetic patients with distal subungual onyc...

  • Article
  • Open Access
9 Citations
11,561 Views
19 Pages

15 November 2023

Autism spectrum disorder (ASD) is a type of neurodevelopmental disorder that has been diagnosed in an increasing number of children around the world. The existing data suggest that early diagnosis and intervention can improve ASD outcomes. The causes...

(This article belongs to the Section Neurosciences)
  • Article
  • Open Access
13 Citations
9,538 Views
15 Pages

Modulation of Dietary Fatty Acids in an Open-Label Study Improves Psoriasis and Dampens the Inflammatory Activation Status

  • Anja Saalbach,
  • Anna-Theresa Seitz,
  • Johannes Kohlmann,
  • Lena Kalweit and ,
  • Lisa Vogt,
  • Lars Selig,
  • Kathrin M. Engel and
  • Jan C. Simon
  • + 3 authors+ 0 author

30 March 2023

Obesity and high abdominal fat mass are risk factors for developing the chronic inflammatory skin disease psoriasis. They are associated with increased incidence, prevalence and severity of the disease. A positive effect of weight loss on psoriasis a...

(This article belongs to the Special Issue Relationships between Dietary Factors and Inflammatory Skin Diseases)
  • Article
  • Open Access
2 Citations
3,071 Views
12 Pages

Efficacy and Safety of Oral Neomycin for the Decolonization of Carbapenem-Resistant Enterobacterales: An Open-Label Randomized Controlled Trial

  • Lalita Tancharoen,
  • Ananya Srisomnuek,
  • Surapee Tiengrim,
  • Narisara Thamthaweechok and ,
  • Teerawit Tangkorskul and
  • Visanu Thamlikitkul
  • + 1 author+ 0 author

Background: Patients with carbapenem-resistant Enterobacterales (CRE) in the gastrointestinal (GI) tract are at risk for subsequent infections and transmission, necessitating contact precautions. Neomycin has shown in vitro activity against CRE in 66...

(This article belongs to the Special Issue Antimicrobial Prescribing, Population Use and Resistance, Impact in Global Health, 2nd Edition)
  • Article
  • Open Access
4 Citations
3,367 Views
9 Pages

Nine-Strain Bacterial Synbiotic Improves Crying and Lowers Fecal Calprotectin in Colicky Babies—An Open-Label Randomized Study

  • Malgorzata Bernatek,
  • Jacek Piątek,
  • Marcin Pszczola,
  • Hanna Krauss and ,
  • Janina Antczak,
  • Paweł Maciukajć and
  • Henning Sommermeyer
  • + 2 authors+ 0 author

The aim of this study (ClinicalTrials.gov registration NCT04666324) was to determine the effects of a nine-strain synbiotic and simethicone on the duration of crying and the gut inflammation marker calprotectin in colicky babies aged 3–6 weeks,...

(This article belongs to the Section Antimicrobial Agents and Resistance)

of 48